ZAI LAB LTD0000006 Total Liabilities

Latest as of March 2026: €433.76 Million EUR ≈ $507.11 Million USD

ZAI LAB LTD0000006 total liabilities. Based on the latest financial reports, ZAI LAB LTD0000006 (1ZLB) has total liabilities worth €433.76 Million EUR (≈ $507.11 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check ZAI LAB LTD0000006 liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of ZAI LAB LTD0000006 (2021–2025)

Total liabilities of ZAI LAB LTD0000006 from 2021 to 2025. This chart illustrates how ZAI LAB LTD0000006's total liabilities have evolved over time, based on quarterly financial data. Explore 1ZLB long-term investment intensity to see how much of total assets are deployed in long-term investments.

ZAI LAB LTD0000006 Competitors by Total Liabilities

The table below lists competitors of ZAI LAB LTD0000006 ranked by their total liabilities.

Company	Country	Total Liabilities
Ziff Davis Inc NASDAQ:ZD	USA	$1.76 Billion
H&R Real Estate Investment Trust TO:HR-UN	Canada	CA$4.97 Billion
Monadelphous Group Ltd F:8MP	Germany	€421.77 Million
Beijing Jiuzhou Yi Gui Environmental Technology Co. Ltd. SHG:688485	China	CN¥518.26 Million
Zhejiang Transfar Co Ltd SHE:002010	China	CN¥19.14 Billion
Parex Resources Inc TO:PXT	Canada	CA$1.88 Billion
Establishment Labs Holdings Inc NASDAQ:ESTA	USA	$330.32 Million
Southchip Semiconductor Technology (Shanghai) Co. Ltd. A SHG:688484	China	CN¥751.22 Million

Liability Composition Analysis (2021–2025)

This chart breaks down ZAI LAB LTD0000006's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see ZAI LAB LTD0000006 balance sheet assets.

Liquidity & Leverage Metrics

ZAI LAB LTD0000006 Total Liabilities Ratios Explained

ZAI LAB LTD0000006 total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	2.40	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.66	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.40	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how ZAI LAB LTD0000006's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for ZAI LAB LTD0000006 (2021–2025)

The table below shows the annual total liabilities of ZAI LAB LTD0000006 from 2021 to 2025.

Year	Total Liabilities	Change
2025-12-31	€456.88 Million ≈ $534.15 Million	+32.49%
2024-12-31	€344.86 Million ≈ $403.17 Million	+43.58%
2023-12-31	€240.18 Million ≈ $280.79 Million	+37.60%
2022-12-31	€174.54 Million ≈ $204.06 Million	-24.11%
2021-12-31	€230.00 Million ≈ $268.89 Million	--

About ZAI LAB LTD0000006

F:1ZLB Germany Biotechnology

Market Cap

$2.55 Billion

€2.18 Billion EUR

Market Cap Rank

#6259 Global

#954 in Germany

Share Price

€1.94

Change (1 day)

-2.02%

52-Week Range

€1.36 - €2.34

All Time High

€152.00